XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2022 $ 8,598 $ 57 $ 27,688 $ (12,975) $ (2,838) $ (4,128) $ 7,804 $ 794
Beginning balance, shares at Dec. 31, 2022   1,217            
Net Income (loss) (1,082)     (1,022)     (1,022) (60)
Other comprehensive income (loss) (156)       (72)   (72) (84)
Issuance of Shares, shares   10            
Stock-based compensation expense 93   93       93  
Dividend to non-controlling interests (67)             (67)
Ending balance at Sep. 30, 2023 7,387 $ 57 27,780 (13,995) (2,910) (4,128) 6,804 582
Ending balance, shares at Sep. 30, 2023   1,227            
Beginning balance at Jun. 30, 2023 7,592 $ 57 27,748 (14,066) (2,677) (4,128) 6,936 656
Beginning balance, shares at Jun. 30, 2023   1,227            
Net Income (loss) 77     69     69 8
Other comprehensive income (loss) (249)       (233)   (233) (16)
Stock-based compensation expense 31   31       31  
Dividend to non-controlling interests (67)             (67)
Ending balance at Sep. 30, 2023 7,387 $ 57 27,780 (13,995) (2,910) (4,128) 6,804 582
Ending balance, shares at Sep. 30, 2023   1,227            
Beginning balance at Dec. 31, 2023 8,126 $ 57 27,807 (13,534) (2,697) (4,128) 7,506 620
Beginning balance, shares at Dec. 31, 2023   1,227            
Net Income (loss) (1,684)     (1,422)     (1,422) (262)
Other comprehensive income (loss) (75)       (69)   (69) (6)
Issuance of Shares, value 1 $ 1         1  
Issuance of Shares, shares   13            
Stock-based compensation expense 89   89       89  
Proceeds from exercise of options 7   7       7  
Dividend to non-controlling interests (18)             (18)
Purchase of shares from non-controlling interests (64)   (45)   (3)   (48) (16)
Ending balance at Sep. 30, 2024 6,383 $ 58 27,860 (14,956) (2,769) (4,128) 6,065 319
Ending balance, shares at Sep. 30, 2024   1,240            
Beginning balance at Jun. 30, 2024 6,563 $ 58 27,829 (14,519) (2,881) (4,128) 6,359 204
Beginning balance, shares at Jun. 30, 2024   1,239            
Net Income (loss) (390)     (437)     (437) 47
Other comprehensive income (loss) 180       113   113 67
Issuance of Shares, shares   1            
Stock-based compensation expense 29   29       29  
Ending balance at Sep. 30, 2024 $ 6,383 $ 58 $ 27,860 $ (14,956) $ (2,769) $ (4,128) $ 6,065 $ 319
Ending balance, shares at Sep. 30, 2024   1,240